Adipokines and treatment with niacin.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2006-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.METABOL.2006.07.002PMID 16979396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adiponectin and adiponectin receptors.

  2005cited by this paper
• Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease.

  2005cited by this paper
• Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin.

  2004cited by this paper
• Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins

  2004cited by this paper
• Association of Hypoadiponectinemia With Coronary Artery Disease in Men

  2003cited by this paper
• Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content.

  2003cited by this paper
• Acipimox stimulates leptin production from isolated rat adipocytes.

  2002cited by this paper
• PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

  2001cited by this paper
• The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients.

  2000cited by this paper
• Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects

  2000cited by this paper
• Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders.

  1996cited by this paper

• Systematic analysis of the experimental and clinical pharmacology of nicotinamide and prospects for the treatment of atherosclerosis

  2023cites this paper
• NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects

  2023cites this paper
• NAD+ homeostasis in human health and disease

  2021cites this paper
• The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential

  2021cites this paper
• The Absence of Adiponectin Alters Niacin’s Effects on Adipose Tissue Inflammation in Mice

  2020cites this paper
• NAD+ homeostasis in health and disease

  2020cites this paper
• Niacin: an old lipid drug in a new NAD+ dress

  2019cites this paper
• Aqueous and ethanolic extracts of welsh onion, Allium fistulosum, attenuate high-fat diet-induced obesity

  2018cites this paper
• Association between vitamin deficiency and metabolic disorders related to obesity

  2017cites this paper
• Modulation of adiponectin as a potential therapeutic strategy.

  2014cites this paper
• Nutritional composition and anti-obesity effects of cereal bar containing Allium fistulosum (welsh onion) extract

  2014cites this paper
• Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome.

  2014cites this paper
• The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.

  2013cites this paper
• Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice

  2013cites this paper
• Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy

  2012cites this paper
• Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

  2012cites this paper
• Evaluación del efecto de niacina en un modelo de obesidad con sindrome metábolico en ratas Zucker-Zucker (fa/fa) longevas Evaluation of the eect of the niacin in a model of obesity with syndrome metabolic in rat Zucker-Zucker (fa/fa) long-lived

  2012cites this paper
• Novel Pleiotropic Effects of Niacin

  2012cites this paper
• Lipid-lowering drugs and circulating adiponectin.

  2012cites this paper
• Synergistic/additive health effects of fish oil and bio-active compounds.

  2011cites this paper
• Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation.

  2011cites this paper
• Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus

  2011cites this paper
• Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus.

  2011cites this paper
• Atherogenic Lipid Metabolism in Obesity

  2011cites this paper
• Pharmacological effects of lipid-lowering drugs on circulating adipokines.

  2010cites this paper
• New evidence for nicotinic acid treatment to reduce atherosclerosis

  2010cites this paper
• Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue.

  2010cites this paper
• Should adipokines be considered in the choice of the treatment of obesity-related health problems?

  2010cites this paper
• Effects of lipid-lowering drugs on adiponectin.

  2010cites this paper
• Hipoadiponektynemia — znaczenie w patogenezie nadciśnienia tętniczego Hypoadiponectinemia — the role in the pathogenesis of arterial hypertension

  2010cites this paper
• The role of resistin as a regulator of inflammation: Implications for various human pathologies.

  2009cites this paper
• Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass.

  2009cites this paper
• Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance.

  2009cites this paper
• Niacin stimulates adiponectin secretion through the GPR109A receptor.

  2009cites this paper
• Preferential increase in high-molecular weight adiponectin after niacin.

  2008cites this paper
• Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers

  2008cites this paper
• Adipokines--targeting a root cause of cardiometabolic risk.

  2008cites this paper
• Increased total and high-molecular weight adiponectin after extended-release niacin.

  2008cites this paper
• Adiponectin multimers in maternal plasma

  2008cites this paper
• Adipose tissue failure and mitochondria as a possible target for improvement by bioactive food components

  2008cites this paper
• Short‐term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men

  2008cites this paper
• Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

  2007cites this paper
• Anti-inflammatory effect is an important property of niacin on atherosclerosis beyond its lipid-altering effects.

  2007cites this paper
• Zastosowanie niacyny w terapii Niacin in therapy

  2007influential citation
• The effects of extended‐release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome

  2007cites this paper
• Studies on lipoprotein kinetics in obesity and the metabolic syndrome: impact of dietary weight loss and statin therapy

  2007cites this paper
• Niacin Stimulates Adiponectin Secretion through the Gpr109a Receptor Materials. All Cell Culture Reagents Were Obtained from Invitrogen (grand Island, Ny). Rabbit Monoclonal and Polyclonal Adiponectin and Leptin Antibodies Were from Affinity Bioreagents (golden, Co). Resistin Polyclonal Antibodies W

  year unknowncites this paper